Device Trial Radar · NCT05380856
Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Aug 18, 2023
Primary completion
Sep 1, 2027
Study completion Sep 1, 2027
Sponsor
- Lead sponsor
- Odense University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Copenhagen; Aarhus University Hospital; Aalborg University Hospital
- First posted
- May 19, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multi-center double-blinded placebo-controlled randomized clinical trial. The patients will be randomized into two groups. To investigate the efficacy of SNM to improve the key bladder diary variables compared to placebo (i.e. sham) for patients with MS having refractory neurogenic lower urinary tract dysfunction (NLUTD). After first step SNM-procedure and a 3-4 weeks test period patients with more than 50% improvement in the key bladder diary variables will have the IPG implanted. After a month of optimization patients will into two groups: IPG ON or IPG OFF. Period of randomization: four months. Number anticipated to be included: 60 patients
Conditions
- Neurogenic Dysfunction of the Urinary Bladder
- Multiple Sclerosis
- Sacral Neuromodulation
- Bowel Dysfunction
- Sexual Dysfunction
- Quality of Life
Interventions
Turning ON the neuromodulatorDevice
IPG on
Turning OFF the neuromodulatorDevice
IPG OFF
Primary outcomes
What the sponsor says the trial is designed to measure.
- Success of SNM for neurogenic lower urinary tract dysfunctionTime frame: Six months
- Male bladder functionTime frame: Six months
- Female bladder functionTime frame: Six months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Odense University Hospital
Odense, Fyn, Denmark · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.